Cytokinetics | CYTK - Umsatzkosten





Umsatzkosten Veränderung Datum
Acadia Pharmaceuticals USD 28.32M 3.52M 2026-06
Amgen USD 1.87B 271M 2026-06
Bayer EUR 5.23B 731M 2026-03
Biogen USD 945.1M 147.6M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Cytokinetics USD 5.59M 5.43M 2026-06
Eisai JPY 51.09B 926M 2026-06
Eli Lilly USD 3.27B 309M 2026-06
Exelixis USD 19.95M 6.53M 2026-03
Geron USD 1.69M 386K 2026-03
Halozyme Therapeutics USD 108.68M 67K 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Ligand Pharmaceuticals USD 11.31M 59K 2026-06
Merck USD 3.14B 200M 2026-06
Novartis USD 3.71B 251M 2026-06
Pfizer USD 4.09B 498M 2026-06
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06